BR112022014586A2 - Colágeno dietário não derivado de animais - Google Patents

Colágeno dietário não derivado de animais

Info

Publication number
BR112022014586A2
BR112022014586A2 BR112022014586A BR112022014586A BR112022014586A2 BR 112022014586 A2 BR112022014586 A2 BR 112022014586A2 BR 112022014586 A BR112022014586 A BR 112022014586A BR 112022014586 A BR112022014586 A BR 112022014586A BR 112022014586 A2 BR112022014586 A2 BR 112022014586A2
Authority
BR
Brazil
Prior art keywords
collagen
derived
dietary
animals
naturally occurring
Prior art date
Application number
BR112022014586A
Other languages
English (en)
Portuguese (pt)
Inventor
Ouzounov Nikolay
R Mellin Jeffrey
Co Julia
Original Assignee
Geltor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltor Inc filed Critical Geltor Inc
Publication of BR112022014586A2 publication Critical patent/BR112022014586A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
BR112022014586A 2020-01-24 2021-01-22 Colágeno dietário não derivado de animais BR112022014586A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062965700P 2020-01-24 2020-01-24
US202063117243P 2020-11-23 2020-11-23
PCT/US2021/014714 WO2021150959A1 (en) 2020-01-24 2021-01-22 Animal-free dietary collagen

Publications (1)

Publication Number Publication Date
BR112022014586A2 true BR112022014586A2 (pt) 2022-09-13

Family

ID=76991717

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022014586A BR112022014586A2 (pt) 2020-01-24 2021-01-22 Colágeno dietário não derivado de animais

Country Status (11)

Country Link
US (3) US11174300B2 (cg-RX-API-DMAC7.html)
EP (1) EP4093761A4 (cg-RX-API-DMAC7.html)
JP (1) JP7794745B2 (cg-RX-API-DMAC7.html)
CN (1) CN115298212A (cg-RX-API-DMAC7.html)
AU (1) AU2021211721A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022014586A2 (cg-RX-API-DMAC7.html)
CA (1) CA3168802A1 (cg-RX-API-DMAC7.html)
GB (1) GB2610313B (cg-RX-API-DMAC7.html)
MX (1) MX2022009036A (cg-RX-API-DMAC7.html)
TW (1) TW202134267A (cg-RX-API-DMAC7.html)
WO (1) WO2021150959A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2597416A (en) 2019-04-12 2022-01-26 Geltor Inc Recombinant elastin and production thereof
EP4093761A4 (en) 2020-01-24 2024-04-17 Geltor, Inc. Animal-free dietary collagen
WO2023009673A1 (en) * 2021-07-28 2023-02-02 Geltor, Inc. Animal-free cosmetic collagens
WO2023009656A1 (en) * 2021-07-28 2023-02-02 Geltor, Inc. Pharmaceutical compositions and methods for treating connective tissue conditions with collagen polypeptides
CN116218864B (zh) * 2023-04-10 2024-01-09 山东多美康生物医药有限公司 一种重组Ⅲ型人源化胶原蛋白α1及其表达载体和应用
WO2024238910A1 (en) * 2023-05-17 2024-11-21 Htl Biotechnology Innovation, Inc. Collagen production process
CN118255873B (zh) * 2024-04-30 2024-11-22 安徽中生安兰健康产业有限公司 重组人源iii型胶原蛋白及基因、表达载体、菌和应用

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
AU3056697A (en) 1996-04-12 1997-11-07 Academy Of Finland Synthesis of human procollagens and collagens in recombinant dna systems
FR2757874B1 (fr) 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
AU1591701A (en) 1999-11-12 2001-06-06 Fibrogen, Inc. Recombinant gelatins
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
TW499433B (en) * 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
CN1500876A (zh) * 2002-11-14 2004-06-02 �й������ž�����ҽѧ��ѧԺ����ҽ 一种编码鸡ⅱ型胶原蛋白的全长多核苷酸序列及其用途
EP1584630A1 (en) 2004-04-08 2005-10-12 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for preparing a modified protein outside a host cell
WO2006091099A2 (en) 2005-02-23 2006-08-31 Fujifilm Manufacturing Europe B.V. Non-glycosylated recombinant collagen-like polypeptides
WO2006133107A2 (en) 2005-06-03 2006-12-14 The Texas A & M University System Specific binding sites in collagen for integrins and use thereof
JP4975751B2 (ja) 2005-10-13 2012-07-11 グ、ジェニファー、エル. ミネラル・コラーゲン・キレートおよびその製造方法と使用方法
US7279329B2 (en) 2005-10-17 2007-10-09 Industrial Technology Research Institute Expression system for producing collagen
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
MX2008011427A (es) 2006-03-13 2008-09-18 Becker & Co Naturinwerk Polvo de colageno y composicion termoplastica basada en colageno para preparar articulos conformados.
EP2054442A2 (en) * 2006-06-14 2009-05-06 Cell-Matrix, Inc. Denatured collagen peptides and uses thereof
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
WO2009053985A1 (en) 2007-10-26 2009-04-30 Collplant Ltd. Methods of processing recombinant procollagen
US7910134B2 (en) 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8507652B2 (en) 2008-02-08 2013-08-13 Luis Eduardo da Cruz Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
GB0820784D0 (en) * 2008-11-13 2008-12-24 Nordic Bioscience As Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments
US9382310B2 (en) 2009-02-06 2016-07-05 Rutgers, The State University Of New Jersey Expression of triple-helical collagen-like products in E. coli
EP3173792B1 (en) * 2009-03-30 2019-06-12 Nordic Bioscience A/S Crp neo-epitope fibrosis assay
WO2011008303A2 (en) 2009-07-17 2011-01-20 The Texas A & M University System Designer collagens and uses thereof
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
CN103641896B (zh) * 2009-11-19 2015-08-05 浙江大学 明胶样单元的用途
AU2011248357B2 (en) * 2010-05-03 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
WO2012149136A1 (en) 2011-04-26 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
CN103842517A (zh) 2011-08-03 2014-06-04 莲花组织修复公司 胶原蛋白7及相关方法
TWI592421B (zh) 2011-08-09 2017-07-21 双美生物科技股份有限公司 一種三重交聯之膠原蛋白、製造方法及其用途
AU2012312170C1 (en) 2011-09-21 2018-01-04 Shiseido Company, Ltd. Compositions and methods for treating conditions of compromised skin barrier function
WO2014050908A1 (ja) * 2012-09-26 2014-04-03 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
EP2941277B1 (en) 2013-01-07 2018-09-05 Ramot at Tel-Aviv University Ltd. Jellyfish-derived polymer
TWI657094B (zh) * 2013-03-21 2019-04-21 全民科學與工業研究機構 三螺旋蛋白質之純化
TWI738631B (zh) 2013-09-09 2021-09-11 德商贏創運營有限公司 經修飾之細菌類膠原蛋白蛋白質
SG11201602012RA (en) 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
US10232008B1 (en) 2015-10-05 2019-03-19 Michael P. Moran Multi-purpose nutritional supplement composition
AU2016354456B2 (en) 2015-11-09 2022-02-17 Shiseido Company, Ltd. Compositions and methods for application over skin
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
CA3015685A1 (en) 2016-03-16 2017-09-21 Phoenix Tissue Repair, Inc. Methods of purifying collagen 7
CN106554410B (zh) 2016-06-02 2019-11-26 陕西东大生化科技有限责任公司 一种重组人源胶原蛋白及其编码基因和制备方法
CN106119322B (zh) 2016-07-22 2019-10-15 江苏江山聚源生物技术有限公司 一种提高重组人源胶原蛋白生产水平的发酵工艺
CN109715197A (zh) 2016-08-30 2019-05-03 嘉利达股份有限公司 胶原水解产物用于改善耐力表现和刺激脂质分解代谢的用途
FR3058142B1 (fr) 2016-10-28 2023-11-24 Gelatines Weishardt Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament
CL2016003387A1 (es) 2016-12-29 2018-10-12 Univ De Santiago De Chile Usach Recubrimiento y/o película comestible para la conservación de productos cárneos
WO2019023555A1 (en) 2017-07-28 2019-01-31 Evelo Biosciences, Inc. POLYMER COMPOSITIONS
WO2019046943A1 (en) 2017-09-06 2019-03-14 University Of Ottawa PROTEINS OF THE COLLAGEN TYPE
US11180541B2 (en) * 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
GB201717134D0 (en) 2017-10-18 2017-12-06 Univ Swansea Monomeric collagen
KR20200126360A (ko) * 2017-11-22 2020-11-06 젤터, 인코포레이티드 콜라겐을 조작하기 위한 방법 및 시스템
DE102018104590A1 (de) 2018-02-28 2019-08-29 Gelita Ag Nutrazeutische oder pharmazeutische Zusammensetzung
CA3135835A1 (en) * 2019-04-01 2020-10-08 Geltor, Inc. Topical formulations of recombinant collagens
EP3976088A4 (en) 2019-06-03 2023-10-11 Société des Produits Nestlé S.A. RECOVERY OF FOOD SUPPLEMENTS
EP4093761A4 (en) 2020-01-24 2024-04-17 Geltor, Inc. Animal-free dietary collagen

Also Published As

Publication number Publication date
JP2023513435A (ja) 2023-03-31
US20220332775A1 (en) 2022-10-20
CN115298212A (zh) 2022-11-04
JP7794745B2 (ja) 2026-01-06
MX2022009036A (es) 2022-11-14
EP4093761A4 (en) 2024-04-17
US11174300B2 (en) 2021-11-16
US20220017581A1 (en) 2022-01-20
TW202134267A (zh) 2021-09-16
EP4093761A1 (en) 2022-11-30
GB2610313A (en) 2023-03-01
AU2021211721A1 (en) 2022-08-18
US11332505B2 (en) 2022-05-17
GB2610313B (en) 2024-07-03
WO2021150959A1 (en) 2021-07-29
GB202212264D0 (en) 2022-10-05
CA3168802A1 (en) 2021-07-29
US20210277075A1 (en) 2021-09-09

Similar Documents

Publication Publication Date Title
IL86480A (en) Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector
MX2022009036A (es) Colageno dietetico no de animales.
MX2019015502A (es) L-asparaginasa modificada.
MX2014011600A (es) Proteínas nutritivas, fragmentos y métodos.
MX358725B (es) Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
RU2009143751A (ru) Производство белков с высоким содержанием маннозы в культуре растительных клеток
MX2020012332A (es) Casetes de expresion de alfa-glucosidasa de acido optimizado con codon y metodos de uso del mismo.
BRPI0919932A8 (pt) Pirrolina-carbóxi-lisina gerada biossinteticamente, bem como processo para preparar método para derivatizar uma proteína
BR112022006233A2 (pt) Composições e métodos para síntese in vivo de polipeptídeos não naturais
AR070058A1 (es) Enzima bacteriana asociada con la sintesis de ecuol
BR112022006842A2 (pt) Construtos de igf2 variante
IN2012DN02981A (cg-RX-API-DMAC7.html)
EP2589658A4 (en) PARTICLE POLYPEPTIDE OF THE REIC / DKK-3 PROTEIN
RU2012126328A (ru) Вакцина против пневмонии, вызываемой streptococcus pneumoniae, на основе гибридного белка
CO2017011431A2 (es) Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina
MY209502A (en) N-terminal extension sequence for expression of recombinant therapeutic peptides
EA202092934A1 (ru) Композиции и способы для посттрансляционной модификации in vivo
MX2020008558A (es) Peptido del antigeno de cancer.
DE602004023927D1 (de) Ghrh zur verwendung bei der behandlung von chronischer niereninsuffizienz
AR118125A2 (es) Péptido, composición, método para identificar células t específicas de péptido fviii, proteína de fusión y método para preparar un péptido fviii
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
NZ751946A (en) Rna-guided nucleic acid modifying enzymes and methods of use thereof
BR112017009515A2 (pt) fitase, método para obter a mesma e uso do mesmo
AR104231A1 (es) Proteínas de fusión inmunogénicas para el tratamiento del cáncer
AR037054A1 (es) Composiciones y metodos de diagnostico y terapia de cancer de pulmon